COVID-19 in children treated with immunosuppressive medication for kidney diseases

BACKGROUND: Children are recognised as at lower risk of severe COVID-19 compared with adults, but the impact of immunosuppression is yet to be determined. This study aims to describe the clinical course of COVID-19 in children with kidney disease taking immunosuppressive medication and to assess dis...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arch Dis Child
Hlavní autoři: Marlais, Matko, Wlodkowski, Tanja, Al-Akash, Samhar, Ananin, Petr, Bandi, Varun Kumar, Baudouin, Veronique, Boyer, Olivia, Vásquez, Luciola, Govindan, Sukanya, Hooman, Nakysa, Ijaz, Iftikhar, Loza, Reyner, Melgosa, Marta, Pande, Nivedita, Pape, Lars, Saha, Anshuman, Samsonov, Dmitry, Schreuder, Michiel F, Sharma, Jyoti, Siddiqui, Sahar, Sinha, Rajiv, Stewart, Heather, Tasic, Velibor, Tönshoff, Burkhard, Twombley, Katherine, Upadhyay, Kiran, Vivarelli, Marina, Weaver, Donald J, Woroniecki, Robert, Schaefer, Franz, Tullus, Kjell
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2021
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754669/
https://ncbi.nlm.nih.gov/pubmed/33355203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/archdischild-2020-320616
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky